How are the results of Oncotype DX used in clinical practice?
In clinical practice, the Recurrence Score from Oncotype DX is used to guide treatment decisions. For instance, a low score may suggest that the patient can safely avoid chemotherapy and rely on hormone therapy alone. Conversely, a high score might indicate a significant benefit from adding chemotherapy to the treatment regimen. The results are integrated with other clinical factors to develop a comprehensive treatment plan.
